Samuel AchilefuJennifer CochranDorin ComaniciuThe National Academy of Engineering elected three cancer researchers—Samuel Achilefu, Jennifer Cochran, Dorin Comaniciu—to its class of 2025, among 128 members and 22 international members.
The governing body of the Cancer Prevention and Research Institute of Texas approved 53 grants totaling more than $67 million to state research institutions to advance the state’s fight against cancer. The grants provide funding for a wide array of cancer projects, including CPRIT Scholar recruitment awards, funding for collaborative core facilities, and support for cancer clinical trials.
Aleksandar Sekulic was named physician-in-chief at the Translational Genomics Research Institute, part of City of Hope.
Boris Naraev, an expert in gastrointestinal, neuroendocrine, and endocrine tumors, joined the Tampa General Hospital Cancer Institute and was appointed as associate professor in the Department of Internal Medicine at the University of South Florida Health Morsani College of Medicine.
Daniel K. Nomura was named editor-in-chief of Molecular Cancer Therapeutics, one of the 10 journals published by the American Association for Cancer Research.
Case Comprehensive Cancer Center was recognized by NCI with a merit award of “outstanding,” 19 months after transitioning to a new director.
Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in 2019.
ASCO and Conquer Cancer, the ASCO Foundation, will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders who have reshaped cancer care around the world with the society’s highest honors at the 2025 ASCO Annual Meeting.
Walter M. Stadler was appointed as the chief clinical officer at City of Hope Cancer Center Chicago.
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from NIH to support the Neuro-Oncology Translational Research Training Program, an initiative designed to train the next generation of brain tumor scientists and physician-scientists.
